EDGAR Filing Documents for 0001628280-22-004522

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001628280-22-004522

Filing Date

2022-03-01

Accepted

2022-03-01 16:20:27

Documents

122

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	akba-20211231.htm iXBRL	10-K	3645719
2	EX-4.5	exhibit45-akebiaequitypurc.htm	EX-4.5	137808
3	EX-10.10	exhibit1010-firstamendment.htm	EX-10.10	79981
4	EX-10.11	exhibit1011-assignmentanda.htm	EX-10.11	20452
5	EX-10.28	exhibit1028-akebiacashince.htm	EX-10.28	18881
6	EX-10.49	exhibit1049-mtpcagreementr.htm	EX-10.49	698095
7	EX-10.54	exhibit1054-akebiaviforsec.htm	EX-10.54	475798
8	EX-10.58	exhibit1058-patheonmasterm.htm	EX-10.58	466641
9	EX-10.64	exhibit1064-amendment4toke.htm	EX-10.64	12421
10	EX-10.69	exhibit1069-amendmentandwa.htm	EX-10.69	58524
11	EX-23.1	exhibit231-eyconsent1.htm	EX-23.1	8756
12	EX-31.1	akbaex3111.htm	EX-31.1	10982
13	EX-31.2	akbaex3121.htm	EX-31.2	11030
14	EX-32.1	akbaex3211.htm	EX-32.1	8313
20		akba-20211231_g1.jpg	GRAPHIC	90072
	Complete submission text file	0001628280-22-004522.txt		17856044

Data Files

Seq	Description	Document	Type	Size
15	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	akba-20211231.xsd	EX-101.SCH	116793
16	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	akba-20211231_cal.xml	EX-101.CAL	134584
17	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	akba-20211231_def.xml	EX-101.DEF	608441
18	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	akba-20211231_lab.xml	EX-101.LAB	1191373
19	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	akba-20211231_pre.xml	EX-101.PRE	869658
116	EXTRACTED XBRL INSTANCE DOCUMENT	akba-20211231_htm.xml	XML	2489737

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142

Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098

Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)